- Home
- HMST vs VNDA Comparison
HMST vs VNDA Comparison
Compare HMST & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- VNDA
- Stock Information
- Founded
- HMST 1921
- VNDA 2002
- Country
- HMST United States
- VNDA United States
- Employees
- HMST N/A
- VNDA N/A
- Industry
- HMST Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- HMST Finance
- VNDA Health Care
- Exchange
- HMST Nasdaq
- VNDA Nasdaq
- Market Cap
- HMST 246.0M
- VNDA 261.7M
- IPO Year
- HMST 2012
- VNDA 2006
- Fundamental
- Price
- HMST $13.09
- VNDA $4.89
- Analyst Decision
- HMST Hold
- VNDA Strong Buy
- Analyst Count
- HMST 3
- VNDA 3
- Target Price
- HMST $14.17
- VNDA $15.33
- AVG Volume (30 Days)
- HMST 68.0K
- VNDA 422.8K
- Earning Date
- HMST 07-28-2025
- VNDA 07-30-2025
- Dividend Yield
- HMST N/A
- VNDA N/A
- EPS Growth
- HMST N/A
- VNDA N/A
- EPS
- HMST N/A
- VNDA N/A
- Revenue
- HMST $78,454,000.00
- VNDA $201,351,000.00
- Revenue This Year
- HMST $161.80
- VNDA $16.86
- Revenue Next Year
- HMST $8.90
- VNDA $39.78
- P/E Ratio
- HMST N/A
- VNDA N/A
- Revenue Growth
- HMST N/A
- VNDA 13.37
- 52 Week Low
- HMST $8.41
- VNDA $3.81
- 52 Week High
- HMST $16.10
- VNDA $6.37
- Technical
- Relative Strength Index (RSI)
- HMST 61.81
- VNDA 64.92
- Support Level
- HMST $12.13
- VNDA $4.66
- Resistance Level
- HMST $12.84
- VNDA $4.95
- Average True Range (ATR)
- HMST 0.38
- VNDA 0.15
- MACD
- HMST 0.04
- VNDA 0.02
- Stochastic Oscillator
- HMST 76.47
- VNDA 89.47
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.